Kessler Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.51M Sell
2,923
-18
-0.6% -$18.4K 1.5% 22
2026
Q1
$2.71M Sell
2,941
-15
-0.5% -$15.2K 1.28% 26
2025
Q4
$3.18M Sell
2,956
-1,091
-27% -$1.04M 1.34% 23
2025
Q3
$3.09M Buy
4,047
+266
+7% +$198K 1.33% 23
2025
Q2
$2.95M Sell
3,781
-3,183
-46% -$2.47M 1.21% 25
2025
Q1
$5.75M Buy
6,964
+876
+14% +$729K 2.81% 18
2024
Q4
$4.7M Buy
6,088
+401
+7% +$332K 2.23% 22
2024
Q3
$5.04M Buy
5,687
+3,211
+130% +$2.89M 2.59% 20
2024
Q2
$2.24M Hold
2,476
1.21% 26
2024
Q1
$1.93M Buy
2,476
+1,840
+289% +$1.31M 1.19% 25
2023
Q4
$371K Hold
636
0.23% 46
2023
Q3
$342K Sell
636
-33
-5% -$17K 0.29% 45
2023
Q2
$314K Buy
669
+33
+5% +$13.8K 0.22% 49
2023
Q1
$218K Hold
636
0.15% 65
2022
Q4
$233K Hold
636
0.25% 51
2022
Q3
$206K Hold
636
0.17% 57
2022
Q2
$206K Hold
636
0.18% 55
2022
Q1
$182K Buy
+636
New +$164K 0.11% 77
2021
Q4
Sell
-400
Closed -$92K 182
2021
Q3
$92K Hold
400
0.07% 91
2021
Q2
$92K Hold
400
0.07% 68
2021
Q1
$75K Hold
400
0.1% 48
2020
Q4
$68K Hold
400
0.07% 60
2020
Q3
$59K Hold
400
0.07% 63
2020
Q2
$66K Sell
400
-25,394
-98% -$3.9M 0.08% 56
2020
Q1
$3.58M Sell
25,794
-3,713
-13% -$510K 4.69% 5
2019
Q4
$3.88M Sell
29,507
-973
-3% -$113K 3.99% 6
2019
Q3
$3.41M Sell
30,480
-377
-1% -$42K 3.81% 6
2019
Q2
$3.42M Sell
30,857
-1,894
-6% -$223K 3.59% 6
2019
Q1
$4.25M Sell
32,751
-1,125
-3% -$137K 4.24% 4
2018
Q4
$3.92M Buy
33,876
+23,804
+236% +$2.66M 5.07% 5
2018
Q3
$1.08M Sell
10,072
-1,116
-10% -$112K 1.11% 26
2018
Q2
$955K Sell
11,188
-430
-4% -$35.3K 1.14% 31
2018
Q1
$899K Sell
11,618
-1,268
-10% -$102K 1.14% 38
2017
Q4
$1.09M Buy
12,886
+102
+0.8% +$8.68K 1.36% 29
2017
Q3
$1.09M Buy
+12,784
New +$1.05M 1.41% 22
2016
Q1
Sell
-37,230
Closed -$3.14M 100
2015
Q4
$3.14M Buy
37,230
+1,280
+4% +$106K 4.96% 2
2015
Q3
$3.01M Sell
35,950
-1,719
-5% -$145K 4.96% 2
2015
Q2
$3.15M Buy
37,669
+349
+0.9% +$26.6K 5.02% 2
2015
Q1
$2.71M Buy
37,320
+200
+0.5% +$14.2K 4.6% 3
2014
Q4
$2.56M Sell
37,120
-34
-0.1% -$2.29K 4.19% 3
2014
Q3
$2.41M Sell
37,154
-174
-0.5% -$11K 4.24% 3
2014
Q2
$2.32M Buy
37,328
+234
+0.6% +$14K 4.09% 4
2014
Q1
$2.18M Buy
37,094
+1,978
+6% +$110K 4.62% 3
2013
Q4
$1.79M Buy
35,116
+1,691
+5% +$84.7K 3.32% 6
2013
Q3
$1.68M Sell
33,425
-7,596
-19% -$398K 4.6% 5
2013
Q2
$2.02M Buy
+41,021
New +$2.23M 5.86% 3

Other funds holding LLY

Kessler Investment Group's LLY Position: Q2 2026 in Review

Kessler Investment Group reduced its Eli Lilly (LLY) stake by 0.61% in Q2 2026, selling an estimated $18.4K and leaving 2,923 shares worth $3.51M. The position accounts for 1.5% of the portfolio, ranked #22.

Kessler Investment Group first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.75M in Q1 2025. 1,221 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kessler Investment Group held 2,923 shares of Eli Lilly worth $3.51M as of Q2 2026.
  • Kessler Investment Group sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 1.5% of Kessler Investment Group's portfolio in Q2 2026, its #22 holding.
  • Kessler Investment Group first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
  • Kessler Investment Group's Eli Lilly position peaked at $5.75M in Q1 2025.
  • 1,221 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kessler Investment Group's 13F filing for Q2 2026, filed 13 Jul 2026.